
Flavio Mantelli, MD, PhD, Chief Medical Officer at Dompé, shares about the company's role in nerve growth factor (NGF) applications in ophthalmic disease and other human indications.
Flavio Mantelli, MD, PhD, Chief Medical Officer at Dompé, shares about the company's role in nerve growth factor (NGF) applications in ophthalmic disease and other human indications.
Danica Marrelli, OD, FAAO, shares key highlights from her presentation, which she presented during the Glaucoma 360 meeting held this year in San Francisco.
Kristen Ingenito, MBA, gives key takeaways from her G360 presentation, "A bird’s eye view of innovation."
Shan Lin, MD, gives key takeaways from his G360 presentation, "The latest in IOLs: When and how to use them?"
Robert Stamper, MD, gives key takeaways from his G360 presentation, "Home tonometry: Worth the pressure?"
CEO and cofounder of the International Keratoconus Academy S. Barry Eiden, OD, FAAO, FSLS, sits down to discuss the inaugural symposium, which will be held April 22-23, 2023, in Scottsdale, Arizona.
Expert eye care specialists comment on the use of aceclidine as a selective miotic for the treatment of presbyopia.
Leo Semes, OD, FAAO, shares key highlights from his EyeCon 2022 presentation, "Advances in therapies for retinal disease."
Marc R. Bloomenstein, OD, FAAO, gives an overview of the SAHARA study.
Selina McGee, OD, FAAO, founder and owner of BeSpoke Vision in Edmond, Oklahoma, shares key takeaways from her discussion, "Pro- and Anti-Inflammatory Cytokine Levels in Tears of Dry Eye Subjects,“ which she presented during the 2022 American Academy of Optometry meeting in San Diego.
Jacqueline Theis, OD, FAAO, gives key takeaways from her AAOpt 2022 meeting presentation, "Ocular and visual complications of Parkinson's disease."
Roland Mattern, director of marketing for eSight, illustrates the use of the company's eSight 4 device to assist patients with central vision loss.
Bindu Manne, lead of Market Development for Ocuphire, shares a company update.
John Buch, OD, MS, with JJV, shares an update on the company's HEV filter contact lens.
Austin Lifferth, OD, FAAO, shares highlights from his AAOpt 2022 presentations, including a triad approach to evaluating the optic nerve in glaucoma, and recentering glaucoma care with these 5 GlaucoMantras.
Denise A. Valenti, OD, FAAO, gives key takeaways from her AAOpt 2022 discussion on the impact of marijuana use and driving.
Pinakin Davey, PhD, OD, FAAO, gives key highlights from his AAOpt 2022 presentation, "Management of digital eye strain: comprehensive strategy and nutritional approach."
Jim Sluck, VP of Marketing for Sight Sciences' TearCare, shares the impetus behind the company's fair access campaign.
Nidhi Rana, OD, discusses key highlights from her AAOpt 2022 presentation on pediatric red eye.
Derek Cunningham, OD, FAAO, gives key takeaways from his AAOpt 2022 discussion, "Back to the basics: The importance of treating inflammation AND obstruction for dry eye."
Marc R. Bloomenstein, OD, FAAO, shares key takeaways from his EyeCon 2022 presentation, "Advances in presbyopia."
Ruth Shoge, OD, MPH, FAAO, shares key takeaways from her EyeCon 2022 presentation, "Diversity in practice, creating an inclusive and equitable workspace."
Jeff Nau, PhD, president and CEO of Oyster Point Pharma shares an update on the company's Tyrvaya product.
Justin Schweitzer, OD, gives a brief overview of his EyeCon 2022 presentations, reflecting on pipeline advancements made in optometry in 2022.
Adam Ramsey, OD, shares key takeaways from his EyeCon 2022 presentation, "Advances in industry innovations to improve your practice."
Optometry Times' EyeCon co-chairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, MA, OD, FAAO, reflect on the 2023 EyeConversations keynote address, which covered new technology, artificial intelligence, and an update in pharmacology.
Mile Brujic, OD, FAAO, shares key takeaways from his EyeCon 2022 presentation, "Advances in presbyopia."
Andrew S. Morgenstern discusses the selectivity of miotic agents in isolating the pupil while limiting adverse events for the management of presbyopia.
Francis S. Mah, MD, reviews miotic agents that are available or under investigation for the treatment of presbyopia.
Lyndon Jones, BSc, PhD, DSc, FCAHS, FCOptom, DipCLP, DipOrth, FAAO, FIACLE, FBCLA , shares key takeaways from his EyeCon 2022 presentation, "Advances in presbyopia."